As an endogenous anti-fibrosis agent, adiponectin exerts a protective effect against liver, renal, and pulmonary fibrosis by inhibiting the activation of myofibroblasts [40,41]. This evidence concerns the gene ADIPOQ and pulmonary fibrosis.